MedTrace Logo

Immersive Virtual Reality Bicycling for Healthy Adults

NCT05253703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-08-18

No results posted yet for this study

Summary

This study has four objectives about healthy younger and older adults during immersive virtual reality bicycling:

Determine the effect of visual feedback and competition for younger healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromuscular and cardiovascular intensity

Determine the effect of visual feedback and competition for older healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromuscular and cardiovascular intensity

Compare younger and older during visual feedback and competition bicycling in terms of: user experience, motivation, enjoyment, perception of effort, neuromuscular and cardiovascular intensity

Determine if attention differs in visual feedback bicycling compared to competition bicycling for younger and older healthy adults

Conditions

  • Healthy

Interventions

OTHER

Virtual reality bicycling

This is a single arm study in which all participants will execute the same three bicycling tasks over one session (see arm/group description).

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Judith E Deutsch · Rutgers School of Health Professions

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-16
Primary Completion
2022-06-07
Completion
2022-06-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253703 on ClinicalTrials.gov